Methylenedioxymethylphenethylamine
   HOME

TheInfoList



OR:

Homarylamine ( INN; also known as 3,4-methylenedioxy-''N''-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug which was patented in 1956 by Merck & Co., but has never been used medically as such. Chemically it is a substituted phenethylamine. It is the '' N''- methylated
analog Analog or analogue may refer to: Computing and electronics * Analog signal, in which information is encoded in a continuous variable ** Analog device, an apparatus that operates on analog signals *** Analog electronics, circuits which use analo ...
of
methylenedioxyphenethylamine 3,4-Methylenedioxyphenethylamine, also known as 3,4-MDPEA, MDPEA, and homopiperonylamine, is a substituted phenethylamine formed by adding a methylenedioxy group to phenethylamine. It is structurally similar to MDA, but without the methyl group ...
(MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.


Reactions

Reaction of homoarylamine with formaldehyde gives hydrastinine.


See also

*
Hydrastine Hydrastine is an isoquinoline alkaloid which was discovered in 1851 by Alfred P. Durand. Hydrolysis of hydrastine yields hydrastinine, which was patented by Bayer as a haemostatic drug during the 1910s. It is present in ''Hydrastis canadensis'' ...
, an alkaloid derivative of homarylamine


References

Phenethylamines Benzodioxoles {{respiratory-system-drug-stub